124 related articles for article (PubMed ID: 14676027)
1. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States.
Heckman BD; Catz SL; Heckman TG; Miller JG; Kalichman SC
AIDS Care; 2004 Feb; 16(2):219-30. PubMed ID: 14676027
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.
Reynolds NR; Testa MA; Marc LG; Chesney MA; Neidig JL; Smith SR; Vella S; Robbins GK;
AIDS Behav; 2004 Jun; 8(2):141-50. PubMed ID: 15187476
[TBL] [Abstract][Full Text] [Related]
3. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.
Catz SL; Kelly JA; Bogart LM; Benotsch EG; McAuliffe TL
Health Psychol; 2000 Mar; 19(2):124-33. PubMed ID: 10762096
[TBL] [Abstract][Full Text] [Related]
4. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
[TBL] [Abstract][Full Text] [Related]
5. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States.
Vyavaharkar M; Moneyham L; Tavakoli A; Phillips KD; Murdaugh C; Jackson K; Meding G
AIDS Patient Care STDS; 2007 Sep; 21(9):667-80. PubMed ID: 17919094
[TBL] [Abstract][Full Text] [Related]
6. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
Luszczynska A; Sarkar Y; Knoll N
Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
[TBL] [Abstract][Full Text] [Related]
7. Barriers to antiretroviral medication adherence in HIV-infected women.
Roberts KJ; Mann T
AIDS Care; 2000 Aug; 12(4):377-86. PubMed ID: 11091770
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
9. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
[TBL] [Abstract][Full Text] [Related]
10. Psychological symptoms among persons 50 years of age and older living with HIV disease.
Heckman TG; Heckman BD; Kochman A; Sikkema KJ; Suhr J; Goodkin K
Aging Ment Health; 2002 May; 6(2):121-8. PubMed ID: 12028880
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
Cruess DG; Minor S; Antoni MH; Millon T
J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
[TBL] [Abstract][Full Text] [Related]
12. Literacy, self-efficacy, and HIV medication adherence.
Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
[TBL] [Abstract][Full Text] [Related]
13. Effects of nurse-delivered home visits combined with telephone calls on medication adherence and quality of life in HIV-infected heroin users in Hunan of China.
Wang H; Zhou J; Huang L; Li X; Fennie KP; Williams AB
J Clin Nurs; 2010 Feb; 19(3-4):380-8. PubMed ID: 20500277
[TBL] [Abstract][Full Text] [Related]
14. Predictors of antiretroviral adherence.
Murphy DA; Marelich WD; Hoffman D; Steers WN
AIDS Care; 2004 May; 16(4):471-84. PubMed ID: 15203415
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR;
Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
[TBL] [Abstract][Full Text] [Related]
17. Predicting adherence to antiretroviral therapy in HIV-infected older adults: the moderating role of gender.
Bianco JA; Heckman TG; Sutton M; Watakakosol R; Lovejoy T
AIDS Behav; 2011 Oct; 15(7):1437-46. PubMed ID: 20632080
[TBL] [Abstract][Full Text] [Related]
18. Symptoms experienced by HIV-infected Individuals on antiretroviral therapy in KwaZulu-Natal, South Africa.
Bhengu BR; Ncama BP; McInerney PA; Wantland DJ; Nicholas PK; Corless IB; McGibbon CA; Davis SM; Nicholas TP; Ros AV
Appl Nurs Res; 2011 Feb; 24(1):1-9. PubMed ID: 20974052
[TBL] [Abstract][Full Text] [Related]
19. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
[TBL] [Abstract][Full Text] [Related]
20. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
